KENYA SHOTWELL: Open Payments
NPI 1740735885 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$301 in 15 payments from 10 companies in 2025. Trend: 2023 $1,001 · 2024 $1,003 · 2025 $301
Food & beverage: $301
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $55 |
| Lilly USA, LLC | 2 | $40 |
| PFIZER INC. | 2 | $37 |
| SANOFI-AVENTIS U.S. LLC | 1 | $33 |
| Novo Nordisk Inc | 2 | $32 |
| Dexcom, Inc. | 1 | $28 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Valinor Pharma, LLC | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: MOUNJARO, UBRELVY, PREVNAR 20, TZIELD, Wegovy, Dexcom G6 Transmitter, ZENPEP, GVOKE HYPOPEN.
Industry payments across MO — which companies pay providers there.
